Zoetis (ZTS) Free Cash Flow (2012 - 2026)
Zoetis' (ZTS) quarterly Free Cash Flow came in at $291.0 million in Q1 2026, down 13.65% year-on-year from $337.0 million in Q1 2025, and up 5.82% on a QoQ basis from $275.0 million in Q4 2025.
Zoetis (ZTS) Free Cash Flow (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has 15 years of Free Cash Flow data on file, last reported at $291.0 million in Q1 2026.
- On a quarterly basis, Free Cash Flow fell 13.65% year-over-year to $291.0 million in Q1 2026; TTM through Mar 2026 was $2.2 billion, a 21.01% decrease from a year earlier, with the FY2025 full-year figure at $2.3 billion, down 22.61% from the prior year.
- Free Cash Flow for Q1 2026 stood at $291.0 million, up from $275.0 million in the prior quarter.
- Over the last five years, Free Cash Flow for ZTS reached as high as $1.3 billion in Q3 2025 and fell as low as -$203.0 million in Q2 2023.
- Historically, Free Cash Flow has averaged $541.2 million across 5 years, with a median of $455.0 million in 2024.
- On a YoY basis, Free Cash Flow climbed as much as 461.88% in 2023 and fell as far as 160.6% in 2023.
- Year by year, Free Cash Flow stood at $160.0 million in 2022, then soared by 461.88% to $899.0 million in 2023, then advanced by 0.78% to $906.0 million in 2024, then slumped by 69.65% to $275.0 million in 2025, then advanced by 5.82% to $291.0 million in 2026.
- Per Business Quant data, the three most recent Free Cash Flow figures were $291.0 million in Q1 2026, $275.0 million in Q4 2025, and $1.3 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | -208.00 Mn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 291.00 Mn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | -373.37 Mn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 363.70 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 348.40 Mn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 144.40 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | -38.00 Mn |
| 10 | Vireo Growth | 10.53 Bn | 10.38 Bn | 59.30 Mn | 1.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 291.00 Mn |
| Mar 31, 2026 | 291.00 Mn |
| Dec 31, 2025 | 275.00 Mn |
| Dec 31, 2025 | 275.00 Mn |
| Sep 30, 2025 | 1.26 Bn |
| Sep 30, 2025 | 1.26 Bn |
| Jun 30, 2025 | 409.00 Mn |
| Jun 30, 2025 | 409.00 Mn |
| Mar 31, 2025 | 337.00 Mn |
| Mar 31, 2025 | 337.00 Mn |
| Dec 31, 2024 | 906.00 Mn |
| Dec 31, 2024 | 906.00 Mn |
| Sep 30, 2024 | 950.00 Mn |
| Sep 30, 2024 | 950.00 Mn |
| Jun 30, 2024 | 639.00 Mn |
| Jun 30, 2024 | 639.00 Mn |
| Mar 31, 2024 | 455.00 Mn |
| Mar 31, 2024 | 455.00 Mn |
| Dec 31, 2023 | 899.00 Mn |
| Dec 31, 2023 | 899.00 Mn |